Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2
Research output: Contribution to journal › Article › peer-review
27Scopus
citations
Fingerprint
Dive into the research topics of 'Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2'. Together they form a unique fingerprint.